Nierenzellkarzinom

StudieTherapieformStatusSubinvestigator
SUNNIFORECAST
A Phase II, randomized, open-label Study of Nivolumab combined with Ipilimumab vs Sunnitinib Monotherapy in subjects with untreated and advanced (unresectabel   or metastatic non-clear Cell Renal Cell Carcinoma)
1st lineoffenLorch/ Albers/ Hiester
MK3475-564
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)
adjuvantoffen bis vorauss. 12/2018Lorch/ Albers/ Hiester
TITAN
A phase II single arm clinical trial of a tailored Immuno Therapy Approach with Nivolumab in Subjects with metatstatic or advanced Renal Cell Carcinoma
2nd lineoffenLorch/ Albers/ Hiester
MediathekInformation und Wissen
LageplanSo finden Sie uns